Ionis Pharmaceuticals Execs Sell and Buy Shares on 2026-02-02
ByAinvest
Wednesday, Feb 4, 2026 4:17 pm ET1min read
IONS--
Ionis Pharmaceuticals Inc. [IONS] has recently announced that Bennett C. Frank, Executive Vice President and Chief Scientific Officer, has executed a series of transactions involving the purchase and sale of company shares. On February 2, 2026, Frank sold 16,463 shares at a price of $83.03 per share, as well as an additional 48,626 shares at the same price. Furthermore, he sold 20,000 shares at a price of $82.60 per share on the same day. In contrast, Frank also executed two purchases of shares, acquiring 48,626 shares at $60.89 per share and 16,463 shares at $32.60 per share.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet